Simple Clinical Prognostic Model for Hepatocellular Carcinoma in Developing Countries and Its Validation
- 15 June 2003
- journal article
- gastrointestinal cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (12), 2294-2298
- https://doi.org/10.1200/jco.2003.03.151
Abstract
Purpose: More than 80% of hepatocellular carcinomas (HCCs) worldwide occur in developing countries, especially in Asia. It often presents at an advanced stage beyond treatment. In this circumstance...Keywords
This publication has 11 references indexed in Scilit:
- High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trialHepatology, 2002
- Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging systemCancer, 2002
- What do we mean by validating a prognostic model?Statistics in Medicine, 2000
- A new prognostic classification for predicting survival in patients with hepatocellular carcinomaJournal of Hepatology, 1999
- A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patientsHepatology, 1998
- Prognosis of unresectable hepatocellular carcinoma: An evaluation based on multivariate analysis of 90 casesHepatology, 1991
- Long survival and prognostic factors in hepatocellular carcinomaJournal of Surgical Oncology, 1990
- Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patientsHepatology, 1990
- Natural History and Prognostic Factors of Primary Hepatocellular Carcinoma: Study of 70 Untreated PatientsThe Korean Journal of Internal Medicine, 1989
- Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong KongCancer, 1981